Skip to content
Search

Latest Stories

PCR tests close in NI but lateral flow test kits continue to be available in community pharmacies

Northern Ireland has announced the closure of free polymerase chain reaction (PCR) test for Covid-19 but lateral flow tests will continue to be free for patients displaying symptoms or people visiting high-risk settings and those providing close personal care.

Anyone with symptoms will no longer be required to take a PCR test, with all testing sites across Northern Ireland closing from Friday (April 22). Instead, people with symptoms have been advised to take lateral flow tests which are still available in over 500 community pharmacies across the country. Those who don’t have symptoms are no longer required to take a lateral flow test, unless they are visiting higher risk settings such as care homes, hospices or hospitals.


Deputy chief medical officer Dr Lourda Geoghegan said: “While prevalence of the virus remains high, the risk of serious illness has been significantly reduced – largely due to the success of our vaccination programme and the use of new Covid-19 treatments. As signalled in the department’s transition plan, these changes are proportionate and necessary at this stage of the pandemic.

“Transmission of Covid-19 in health and social care settings remains a risk and adds to the demands and pressures on our workforce. Anyone visiting friends or family in these settings should continue to take a lateral flow test before their visit.”

Isolation guidance for household contacts is also changing. Daily lateral flow testing is no longer advised. Household contacts are asked to be alert to symptoms and should only test if they develop symptoms. This applies to both vaccinated and unvaccinated household contacts. There is no change at this time to the guidance on isolation for positive cases.

Concluding, Dr Geoghegan said: “At this time it is important that we focus contact tracing services to help protect those at higher risk. Household contacts of a positive case are at greater risk of contracting the virus.

"Positive cases and their households will therefore continue to be provided with the necessary public health advice. It also remains vital that those at higher risk and who may be eligible for Covid-19 treatments, take a lateral flow test as soon as symptoms develop, even if symptoms are mild, as treatments should commence quickly following a positive test result.

“I urge everyone to find out if they are eligible to access lateral flow tests under the new arrangements by visiting NI Direct. We should continue to protect those at higher risk by testing if we have symptoms and isolating if we receive a positive test result.”

Test and Trace policy will be kept under review during the ongoing period of transition up until the end of June.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less